Lance R Thurlow

Dr. Lance R Thurlow


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 September 2024 in Infection and Immunity
Verified
Journal Article
Open access
BDBenjamin P. Darwitz
Benjamin P. Darwitz
CGChristopher J. Genito
Christopher J. Genito
LTLance R Thurlow
Lance R Thurlow
Diabetes mellitus, characterized by impaired insulin signaling, is associated with increased incidence and severity of infections. Various diabetes-related complications contribute to exacerbated bacterial infections, including hyperglycemia, innate immune cell dysfunction, and infection with antibiotic-resistant bacterial strains. One defining symptom of diabetes is hyperglycemia, resulting in elevated blood and tissue glucose concentrations. Glucose is the preferred carbon source of several bacterial pathogens, and hyperglycemia escalates bacterial growth and virulence. Hyperglycemia promotes specific mechanisms of bacterial virulence known to contribute to infection chronicity, including tissue adherence and biofilm formation. Foot infections are a significant source of morbidity in individuals with diabetes and consist of biofilm-associated polymicrobial communities. Bacteria perform complex interspecies behaviors conducive to their growth and virulence within biofilms, including metabolic cross-feeding and altered phenotypes more tolerant to antibiotic therapeutics. Moreover, the metabolic dysfunction caused by diabetes compromises immune cell function, resulting in immune suppression. Impaired insulin signaling induces aberrations in phagocytic cells, which are crucial mediators for controlling and resolving bacterial infections. These aberrancies encompass altered cytokine profiles, the migratory and chemotactic mechanisms of neutrophils, and the metabolic reprogramming required for the oxidative burst and subsequent generation of bactericidal free radicals. Furthermore, the immune suppression caused by diabetes and the polymicrobial nature of the diabetic infection microenvironment may promote the emergence of novel strains of multidrug-resistant bacterial pathogens. This review focuses on the “triple threat” linked to worsened bacterial infections in individuals with diabetes: (i) altered nutritional availability in diabetic tissues, (ii) diabetes-associated immune suppression, and (iii) antibiotic treatment failure.

13 November 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
LTLance R Thurlow
Lance R Thurlow
ASAmelia C. Stephens
Amelia C. Stephens
KHKelly E. Hurley
Kelly E. Hurley
ARAnthony R. Richardson
Anthony R. Richardson
Nutritional immunity defects explain the severity of S. aureus skin infections in patients with diabetes.

19 March 2018 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
MGMelinda R Grosser
Melinda R Grosser
EPElyse Paluscio
Elyse Paluscio
LTLance R Thurlow
Lance R Thurlow
MDMarcus M Dillon
Marcus M Dillon
VCVaughn S Cooper
Vaughn S Cooper
ARAnthony R Richardson
Anthony R Richardson
Staphylococcus aureus exhibits many defenses against host innate immunity, including the ability to replicate in the presence of nitric oxide (NO·). S. aureus NO· resistance is a complex trait and hinges on the ability of this pathogen to metabolically adapt to the presence of NO·. Here, we employed deep sequencing of transposon junctions (Tn-Seq) in a library generated in USA300 LAC to define the complete set of genes required for S. aureus NO· resistance. We compared the list of NO·-resistance genes to the set of genes required for LAC to persist within murine skin infections (SSTIs). In total, we identified 168 genes that were essential for full NO· resistance, of which 49 were also required for S. aureus to persist within SSTIs. Many of these NO·-resistance genes were previously demonstrated to be required for growth in the presence of this immune radical. However, newly defined genes, including those encoding SodA, MntABC, RpoZ, proteins involved with Fe-S-cluster repair/homeostasis, UvrABC, thioredoxin-like proteins and the F1F0 ATPase, have not been previously reported to contribute to S. aureus NO· resistance. The most striking finding was that loss of any genes encoding components of the F1F0 ATPase resulted in mutants unable to grow in the presence of NO· or any other condition that inhibits cellular respiration. In addition, these mutants were highly attenuated in murine SSTIs. We show that in S. aureus, the F1F0 ATPase operates in the ATP-hydrolysis mode to extrude protons and contribute to proton-motive force. Loss of efficient proton extrusion in the ΔatpG mutant results in an acidified cytosol. While this acidity is tolerated by respiring cells, enzymes required for fermentation cannot operate efficiently at pH ≤ 7.0 and the ΔatpG mutant cannot thrive. Thus, S. aureus NO· resistance requires a mildly alkaline cytosol, a condition that cannot be achieved without an active F1F0 ATPase enzyme complex. The human pathogen Staphylococcus aureus is remarkably resistant to many facets of the host immune response, including the antibacterial radical nitric oxide (NO·). The mechanism underlying this resistance is complex and comprises many gene products. Here we employ an approach that involves transposon mutagenesis coupled to next-generation sequencing (known as Tn-Seq) to identify the complete set of genes required for S. aureus NO· resistance and virulence. While we identified many previously reported NO·-resistance determinants, new gene products were discovered from this untargeted approach. Specifically, we identified the F1F0 ATPase as being essential during NO· stress and virulence yet dispensable under normal culture conditions. The reason for this conditional fitness contribution stems from the fact that under fermentative conditions, the F1F0 ATPase functions in the ATP hydrolysis mode, effectively extruding protons and raising the intracellular pH above 8.0. This happens to be the optimal pH for many fermentation enzymes. Without the F1F0 ATPase, proton extrusion is limited and the intracellular pH remains too low for efficient fermentation to continue. Thus, during infection when S. aureus must ferment due to the nature of inflamed tissue, the F1F0 ATPase becomes an essential enzyme complex and a valid target for the development of new antimicrobials.

14 February 2025 in Science Advances
Verified
Journal Article
Open access
JSJohn C. Shook
John C. Shook
CGChristopher J. Genito
Christopher J. Genito
BDBenjamin P. Darwitz
Benjamin P. Darwitz
KTKaleb J. Tyson
Kaleb J. Tyson
AVAmanda Z. Velez
Amanda Z. Velez
LTLance R Thurlow
Lance R Thurlow
Individuals with diabetes mellitus frequently develop severe skin and soft tissue infections (SSTIs) that are recalcitrant to antibiotic treatment. We examined how diabetes affects the emergence of antibiotic resistance in a Staphylococcus aureus SSTI. We determined that S. aureus evolves antibiotic resistance rapidly in diabetic mice, while resistance did not occur in nondiabetic mice over the course of infection. Diabetes-associated immune cell dysfunction plays a minor role in the emergence of resistance, while hyperglycemia plays a dominant role facilitating the expansion and takeover of resistant mutants in diabetic infections. Furthermore, vancomycin intermediate resistant isolates display a pronounced fitness defect in nondiabetic mice but not in diabetic mice. Together, these data suggest that the diabetic infection environment represents an ideal reservoir for the emergence and proliferation of antibiotic resistance. Controlling the blood sugar of diabetic mice with insulin resulted in significantly decreased incidence of antibiotic-resistant S. aureus .

1 August 2018 in Cell Host & Microbe
Verified
Journal Article
Closed access
LTLance R Thurlow
Lance R Thurlow
GJGauri S. Joshi
Gauri S. Joshi
ARAnthony R. Richardson
Anthony R. Richardson

15 November 2017 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
JHJon A Hagar
Jon A Hagar
MEMatthew Edin
Matthew Edin
FLFred B. Lih
Fred B. Lih
LTLance R Thurlow
Lance R Thurlow
BKBeverly H. Koller
Beverly H. Koller
EMEdward A Miao
Edward A Miao
Critically ill patients typically present with hyperglycemia. Treatment with conventional insulin therapy (targeting 144–180 mg/dl) improves patient survival; however, intensive insulin therapy (IIT) targeting normal blood glucose levels (81–108 mg/dl) increases the incidence of moderate and severe hypoglycemia, and increases mortality. Septic patients are especially prone to IIT-induced hypoglycemia, but the mechanism remains unknown. Here, we show that codelivery of insulin with otherwise sublethal doses of LPS induced hypoglycemic shock in mice within 1–2 h. LPS impaired clearance of insulin, which amplified insulin receptor signaling. These effects were mediated by caspase-11, TLR4, and complement, each of which trigger eicosanoid production that potentiates insulin signaling. Finally, in an animal model of sepsis, we observed that Salmonella typhimurium–infected mice exhibited simultaneous impaired insulin clearance coexisting with insulin resistance. Our results raise the possibility that septic patients have impaired insulin clearance, which could increase their susceptibility to hypoglycemia during IIT, contraindicating its use.